Vimarsana
Biggest News Aggregation in the World

Page 20 - Aallergic News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Aallergic. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Aallergic Today - Breaking & Trending Today

Safely Determine Vaccine Hypersensitivity  Labmate Online - Vimarsana News

Safely Determine Vaccine Hypersensitivity  Labmate Online

Alpha Laboratories Ltd is pleased to introduce the new Polyethylene glycol allergens from Bühlmann to the UK. Click to read more...

People with allergic conditions have up to 40% lower risk of getting Covid infection - Vimarsana News

People with allergic conditions have up to 40% lower risk of getting Covid infection

People with allergic conditions such as hay fever have a lower risk of being infected by Covid, a new study suggests, the Daily Mail reported.

The Lancet Regional Health - Europe publishes 'real-world evidence' from ALK-sponsored study confirming long-term benefits of allergy immunotherapy in allergic rhinitis and asthma - Vimarsana News

The Lancet Regional Health - Europe publishes 'real-world evidence' from ALK-sponsored study confirming long-term benefits of allergy immunotherapy in allergic rhinitis and asthma

- Results from ALK-sponsored REACT (REAl-world effeCTtiveness of allergy immunotherapy) study have been published in The Lancet Regional Health - Europe - REACT demonstrated the real-world

Altamira Therapeutics Announces Randomization of First Patient in Bentrio Trial in Seasonal Allergic Rhinitis - Vimarsana News

Altamira Therapeutics Announces Randomization of First Patient in Bentrio Trial in Seasonal Allergic Rhinitis

HAMILTON, BERMUDA / ACCESSWIRE / December 1, 2021 / Altamira Therapeutics Ltd. (NASDAQ:CYTO), a company dedicated to addressing unmet medical needs through RNA therapeutics, allergy and viral infection

A real shot in the arm for anaphylaxis - Vimarsana News

A real shot in the arm for anaphylaxis

New guidelines outlining the standard of care for those experiencing anaphylaxis in Australia have been released.